000 00962 a2200253 4500
005 20250515070810.0
264 0 _c20071003
008 200710s 0 0 eng d
022 _a0022-510X
024 7 _a10.1016/j.jns.2006.04.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRansohoff, Richard M
245 0 0 _a"Thinking without thinking" about natalizumab and PML.
_h[electronic resource]
260 _bJournal of the neurological sciences
_cAug 2007
300 _a50-2 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aHumans
650 0 4 _aLeukoencephalopathy, Progressive Multifocal
_xdrug therapy
650 0 4 _aNatalizumab
773 0 _tJournal of the neurological sciences
_gvol. 259
_gno. 1-2
_gp. 50-2
856 4 0 _uhttps://doi.org/10.1016/j.jns.2006.04.011
_zAvailable from publisher's website
999 _c17065240
_d17065240